HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Modulation of mitochondria and NADPH oxidase function by the nitrate-nitrite-NO pathway in metabolic disease with focus on type 2 diabetes.

Abstract
Mitochondria play fundamental role in maintaining cellular metabolic homeostasis, and metabolic disorders including type 2 diabetes (T2D) have been associated with mitochondrial dysfunction. Pathophysiological mechanisms are coupled to increased production of reactive oxygen species and oxidative stress, together with reduced bioactivity/signaling of nitric oxide (NO). Novel strategies restoring these abnormalities may have therapeutic potential in order to prevent or even treat T2D and associated cardiovascular and renal co-morbidities. A diet rich in green leafy vegetables, which contains high concentrations of inorganic nitrate, has been shown to reduce the risk of T2D. To this regard research has shown that in addition to the classical NO synthase (NOS) dependent pathway, nitrate from our diet can work as an alternative precursor for NO and other bioactive nitrogen oxide species via serial reductions of nitrate (i.e. nitrate-nitrite-NO pathway). This non-conventional pathway may act as an efficient back-up system during various pathological conditions when the endogenous NOS system is compromised (e.g. acidemia, hypoxia, ischemia, aging, oxidative stress). A number of experimental studies have demonstrated protective effects of nitrate supplementation in models of obesity, metabolic syndrome and T2D. Recently, attention has been directed towards the effects of nitrate/nitrite on mitochondrial functions including beiging/browning of white adipose tissue, PGC-1α and SIRT3 dependent AMPK activation, GLUT4 translocation and mitochondrial fusion-dependent improvements in glucose homeostasis, as well as dampening of NADPH oxidase activity. In this review, we examine recent research related to the effects of bioactive nitrogen oxide species on mitochondrial function with emphasis on T2D.
AuthorsTomas A Schiffer, Jon O Lundberg, Eddie Weitzberg, Mattias Carlström
JournalBiochimica et biophysica acta. Molecular basis of disease (Biochim Biophys Acta Mol Basis Dis) Vol. 1866 Issue 8 Pg. 165811 (08 01 2020) ISSN: 1879-260X [Electronic] Netherlands
PMID32339643 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
CopyrightCopyright © 2020 Elsevier B.V. All rights reserved.
Chemical References
  • Fatty Acids
  • Glycated Hemoglobin A
  • hemoglobin A1c protein, human
  • Nitric Oxide
  • Nitric Oxide Synthase
  • NADPH Oxidases
Topics
  • Animals
  • Diabetes Mellitus, Experimental (genetics, metabolism, pathology)
  • Diabetes Mellitus, Type 2 (genetics, metabolism, pathology)
  • Dyslipidemias (genetics, metabolism, pathology)
  • Fatty Acids (metabolism)
  • Gene Expression Regulation
  • Glycated Hemoglobin (genetics, metabolism)
  • Humans
  • Metabolic Syndrome (genetics, metabolism, pathology)
  • Mitochondria (metabolism, pathology)
  • NADPH Oxidases (genetics, metabolism)
  • Nitric Oxide (metabolism)
  • Nitric Oxide Synthase (genetics, metabolism)
  • Obesity (genetics, metabolism, pathology)
  • Oxidation-Reduction
  • Oxidative Stress
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: